Search

for
Search:

GlossaryDoxorubicin (Adriamycin)

chemotherapy drug that interferes with cancer cell DNA

Doxorubicin, also known as Adriamycin, is a chemotherapy drug used to treat various types of cancer, including breast cancer, bladder cancer, and lymphoma. It works by interfering with the DNA inside cancer cells, preventing them from growing and dividing. However, it can also cause side effects such as hair loss (alopecia) and damage to the heart, so its use is carefully monitored by healthcare professionals.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 176 results

research Results of Ifosfamide Combination Chemotherapy in Patients with Advanced Soft Tissue Sarcomas

4 citations , January 1987 in “Beiträge zur Onkologie/Contributions to oncology”

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Postoperative Chemotherapy and Tamoxifen Compared with Tamoxifen Alone in the Treatment of Positive-Node Breast Cancer Patients Aged 50 Years and Older with Tumors Responsive to Tamoxifen: Results from the National Surgical Adjuvant Breast and Bowel Project B-16

research Postoperative Chemotherapy and Tamoxifen Compared with Tamoxifen Alone in the Treatment of Positive-Node Breast Cancer Patients Aged 50 Years and Older with Tumors Responsive to Tamoxifen: Results from the National Surgical Adjuvant Breast and Bowel Project B-16

279 citations , June 1990 in “Journal of Clinical Oncology”

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

research Vitamin D3 and Chemotherapy-Induced Alopecia

11 citations , June 1996 in “Nutrition”

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

research Development of New Treatment Modality for Male Infertility Using Phytopharmaceuticals

September 2018 in “Translational andrology and urology”

MOTILIPERM may help treat male infertility by reducing stress in cells.

research Prolonged Remissions of Metastatic Breast Cancer Achieved With a Six-Drug Regimen of Relatively Low Toxicity

6 citations , June 1983 in “Cancer”

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

View more "adriamycin" in research →

Community Join

0 / 0 results

— no results